Last update 24 Mar 2025

FR-227673

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
FR 227673, FR227673
Target
1,3-beta-glucan synthase
Action
inhibitors
Mechanism
1,3-beta-glucan synthase inhibitors
Therapeutic Areas
Infectious Diseases
Active Indication-
Inactive Indication
Mycoses
Originator Organization
Fujisawa Pharmaceutical Co., Ltd.
Active Organization-
Inactive Organization
Fujisawa Pharmaceutical Co., Ltd.
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC53H86N8O21S
InChIKeyXEIJPGKRYOZUGB-UHFFFAOYSA-N
CAS Registry-

Related

100 Clinical Results associated with FR-227673
Login to view more data
100 Translational Medicine associated with FR-227673
Login to view more data
100 Patents (Medical) associated with FR-227673
Login to view more data
1
Literatures (Medical) associated with FR-227673
01 Mar 2006The Journal of antibioticsQ4 · MEDICINE
FR227673 and FR190293, Novel Antifungal Lipopeptides from Chalara sp. No. 22210 and Tolypocladium parasiticum No. 16616
Q4 · MEDICINE
100 Deals associated with FR-227673
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
MycosesPreclinical
Japan
Fujisawa Pharmaceutical Co., Ltd.
01 Mar 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free